SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-18-000052
Filing Date
2018-06-15
Accepted
2018-06-15 16:31:14
Documents
1
Period of Report
2018-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE q22018form8-kstockholderme.htm 8-K 59498
  Complete submission text file 0001358403-18-000052.txt   60683
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 18902586
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences